Symptoms and the Biology of Infantile Refsum Disease
At a Glance
Infantile Refsum Disease (IRD) is a genetic disorder caused by PEX gene mutations that impair cell function. It primarily impacts a child's vision, hearing, liver health, and neurodevelopment. Because severity varies, ongoing monitoring and early intervention are crucial for managing symptoms.
Understanding the biology of Infantile Refsum Disease (IRD) helps make sense of the diverse symptoms your child may experience. IRD is a peroxisome biogenesis disorder, meaning the body struggles to “build” the essential machinery needed for cells to function correctly [1][2].
The Biological Blueprint: PEX Genes and Peroxisomes
Every cell in the body relies on peroxisomes to manage chemical reactions. These tiny structures are built using instructions from PEX genes, such as PEX1, PEX6, PEX10, or PEX26 [1][3].
When these genes have mutations, the “assembly line” for building peroxisomes breaks down:
- Import Failure: In many cases, the cell can make the outer shell of the peroxisome, but it cannot “import” the necessary enzymes inside [1][4].
- Peroxisomal Ghosts: This results in “ghosts”—empty, non-functional structures that cannot perform their jobs [5][6].
- Metabolic Backup: Without working peroxisomes, toxic substances (like Very Long Chain Fatty Acids) build up, while essential fats (like plasmalogens) that protect the brain and eyes are not produced [7][8].
Vision and Hearing: The Sensory Impact
Because the eyes and ears are highly active organs that require specific fats for protection, they are often the first areas where symptoms appear in IRD [9].
- Vision (Retinitis Pigmentosa-like changes): Most children develop a condition similar to retinitis pigmentosa, where the light-sensing cells in the back of the eye (the retina) gradually break down [10]. Over time, this can lead to “tunnel vision” or difficulty seeing in low light. Doctors use advanced imaging like optical coherence tomography (OCT) to track these changes [11][9].
- Hearing (Sensorineural Hearing Loss): This is caused by damage to the tiny hair cells in the inner ear or the nerves that send sound to the brain [9]. It is often progressive, meaning it may start as mild and become more significant as the child grows [10].
Hepatic (Liver) Disease and Progression
The liver is the body’s primary metabolic hub, making it very sensitive to peroxisomal dysfunction [12].
- Early Signs: Some infants may experience jaundice (yellowing of the skin) or an enlarged liver shortly after birth. In some cases of IRD, these early liver issues may actually appear to improve or “self-resolve” for a period of time [10].
- Long-term Risks: Despite early improvement, the liver remains at risk. Over years, the buildup of toxic metabolites can lead to fibrosis (scarring) or cirrhosis (advanced scarring) [12][13].
- Monitoring: Because of the risk of developing liver tumors (hepatocellular carcinoma), regular ultrasounds and blood tests are a standard part of long-term care [12].
Intellectual and Developmental Factors
IRD is characterized by a “heterogeneous” course, which is a medical way of saying it looks different for every child [9]. Most children experience some degree of neurodevelopmental delay, affecting how they learn to move, speak, and interact [10].
However, because IRD is on the milder end of the spectrum, many children continue to gain skills and reach milestones at their own pace. Early Intervention (EI) programs and Individualized Education Programs (IEPs) are critical practical tools to support your child’s cognitive and physical development [2][10].
Common questions in this guide
What causes Infantile Refsum Disease?
What are peroxisomal ghosts?
How does Infantile Refsum Disease affect my child's vision and hearing?
What are the long-term liver complications associated with IRD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How does my child's specific PEX mutation affect their level of 'functional residual activity' in their peroxisomes?
- 2.What is the current stage of my child’s liver health (e.g., is there evidence of fibrosis or cirrhosis)?
- 3.How frequently should we be performing retinal imaging to track the progression of the vision changes?
- 4.Can you explain the difference between 'peroxisomal ghosts' and functional peroxisomes in the context of my child's diagnosis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Peroxisome: Metabolic Functions and Biogenesis.
Okumoto K, Tamura S, Honsho M, Fujiki Y
Advances in experimental medicine and biology 2020; (1299()):3-17 doi:10.1007/978-3-030-60204-8_1.
PMID: 33417203 - 2
Severe Zellweger spectrum disorder due to a novel missense variant in the PEX13 gene: A case report and the literature review.
Su L, Peng MZ, Chen XD, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2315 doi:10.1002/mgg3.2315.
PMID: 37962062 - 3
The N1 domain of the peroxisomal AAA-ATPase Pex6 is required for Pex15 binding and proper assembly with Pex1.
Ali BA, Judy RM, Chowdhury S, et al.
The Journal of biological chemistry 2024; (300(1)):105504 doi:10.1016/j.jbc.2023.105504.
PMID: 38036174 - 4
Insights into the Structure and Function of the Pex1/Pex6 AAA-ATPase in Peroxisome Homeostasis.
Judy RM, Sheedy CJ, Gardner BM
Cells 2022; (11(13)) doi:10.3390/cells11132067.
PMID: 35805150 - 5
Super-resolution imaging reveals the sub-diffraction phenotype of Zellweger Syndrome ghosts and wild-type peroxisomes.
Soliman K, Göttfert F, Rosewich H, et al.
Scientific reports 2018; (8(1)):7809 doi:10.1038/s41598-018-24119-2.
PMID: 29773809 - 6
Compound heterozygous p. Arg949Trp and p. Gly970Ala mutations deteriorated the function of PEX1p: A study on PEX1 in a patient with Zellweger syndrome.
Alamatsaz M, Jalalypour F, Hashemi MS, et al.
Journal of cellular biochemistry 2021; doi:10.1002/jcb.29945.
PMID: 33955040 - 7
Role of peroxisomes in the pathogenesis and therapy of renal fibrosis.
Zhang D, Zhang YH, Liu B, et al.
Metabolism: clinical and experimental 2025; (166()):156173 doi:10.1016/j.metabol.2025.156173.
PMID: 39993498 - 8
Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders.
Jaspers YRJ, Ferdinandusse S, Dijkstra IME, et al.
Frontiers in cell and developmental biology 2020; (8()):690 doi:10.3389/fcell.2020.00690.
PMID: 32903870 - 9
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.
Georgiou M, Robson AG, Fujinami K, et al.
Progress in retinal and eye research 2024; (100()):101244 doi:10.1016/j.preteyeres.2024.101244.
PMID: 38278208 - 10
Ophthalmic Diagnosis and Novel Management of Infantile Refsum Disease with Combination Docosahexaenoic Acid and Cholic Acid.
Elghawy O, Zhang AY, Duong R, et al.
Case reports in ophthalmological medicine 2021; (2021()):1345937 doi:10.1155/2021/1345937.
PMID: 34664020 - 11
Utility of multimodal imaging in the clinical diagnosis of inherited retinal degenerations.
Lee BJH, Sun CZY, Ong CJT, et al.
Taiwan journal of ophthalmology 2024; (14(4)):486-496 doi:10.4103/tjo.TJO-D-24-00066.
PMID: 39803408 - 12
Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.
Berendse K, Koot BGP, Klouwer FCC, et al.
Journal of inherited metabolic disease 2019; (42(5)):955-965 doi:10.1002/jimd.12132.
PMID: 31150129 - 13
Histologic and ultrastructural features in early and advanced phases of Zellweger spectrum disorder (infantile Refsum disease).
Warren M, Mierau G, Wartchow EP, et al.
Ultrastructural pathology 2018; (42(3)):220-227 doi:10.1080/01913123.2018.1440272.
PMID: 29482424
This page provides educational information about the biology and symptoms of Infantile Refsum Disease. It is not intended as medical advice, and you should always consult your child's pediatric specialist or geneticist for personalized care.
Get notified when new evidence is published on Infantile Refsum disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.